In combination with ICIs therapy, hepatitis is mainly manifested by abnormal liver function, including alanine aminotransferase increased, aspartate aminotransferase increased, and occasionally bilirubin increase (Figure 3C) (Table 6). This evidence concerns the gene GPT and hepatitis A virus infection.